CJC-1295

Category: Growth hormone-releasing hormone (GHRH) analog

Studied or approved for: Growth hormone release (research)

Regulatory status: NOT FDA-APPROVED; removed from FDA compounding categories. Prohibited by WADA.

Typical administration: Injection (research settings)

Educational purposes only — not medical advice. Peptiverse.net does not sell or prescribe peptides. Consult a qualified healthcare professional. Full disclaimer: /disclaimer/.